A low thyroglobulin level cannot be used to avoid adjuvant 131i therapy after thyroidectomy for thyroid carcinoma

A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma
Content Type Journal ArticleCategory Editorial commentaryDOI 10.1007/s00259-008-0963-2Authors
Paolo Zanotti-Fregonara, Commissariat à l’Energie Atomique DSV/I2BM/SHFJ/LMNRB Orsay FranceGaia Grassetto, ‘S. Maria della Misericordia’ Hospital Department of Nuclear Medicine, PET Centre Viale Tre Martiri, 140 45100 Rovigo ItalyElif Hindié, Saint-Louis Hospital Department of Nuclear Medicine Paris FranceDomenico Rubello, ‘S. Maria della Misericordia’ Hospital Department of Nuclear Medicine, PET Centre Viale Tre Martiri, 140 45100 Rovigo Italy

Journal European Journal of Nuclear Medicine and Molecular ImagingOnline ISSN 1619-7089Print ISSN 1619-7070 (Source: European Journal of Nuclear Medicine and Molecular Imaging)